Positive Press Coverage Somewhat Unlikely to Affect Blackrock Health Sciences Trust (BME) Stock Price

Press coverage about Blackrock Health Sciences Trust (NYSE:BME) has been trending positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Blackrock Health Sciences Trust earned a news impact score of 0.39 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 46.4661407455135 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Shares of BME stock opened at $34.97 on Friday. Blackrock Health Sciences Trust has a 1-year low of $32.81 and a 1-year high of $38.00.

How to Become a New Pot Stock Millionaire

The firm also recently disclosed a monthly dividend, which will be paid on Monday, April 30th. Investors of record on Monday, April 16th will be issued a dividend of $0.20 per share. This represents a $2.40 dividend on an annualized basis and a yield of 6.86%. The ex-dividend date is Friday, April 13th.

WARNING: “Positive Press Coverage Somewhat Unlikely to Affect Blackrock Health Sciences Trust (BME) Stock Price” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/04/13/positive-press-coverage-somewhat-unlikely-to-affect-blackrock-health-sciences-trust-bme-stock-price.html.

About Blackrock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.

Insider Buying and Selling by Quarter for Blackrock Health Sciences Trust (NYSE:BME)

Receive News & Ratings for Blackrock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blackrock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply